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Local intra-uterine Ang-(1–7) infusion
attenuates PGE2 and 6-keto PGF1α in
decidualized uterus of pseudopregnant rats
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Abstract
Background: Cyclooxygenase (COX)-derived prostanoids (PGE2, PGI2) are important contributors to the process of
decidualization. Previous studies showed the presence of Ang-(1-7) in the primary and secondary decidualized
zones of the implantation site at early pregnancy. Decreased concentrations of Ang-(1-7) were found in the
decidualized uterus compared to the non-decidualized uterus of pseudopregnant rats, suggesting that low levels of
Ang-(1-7) are required for successful decidualization at early pregnancy.
Methods: To understand the role of Ang-(1-7) in prostaglandin production in a decidualized uterus, induced by a
bolus injection of sesame oil, Ang-(1-7) (24 μg/kg/h) or vehicle was then infused directly into the decidualized
uterine horn using an osmotic minipump. The right horns were not injected or infused and served as nondecidualized uterine horns in both groups of animals.
Results: Decidualization increased PGE2 concentration in the uterus (0.53 ± 0.05 vs. 12.0 ± 3.2 pmol/mg protein,
p < 0.001, non-decidualized vs. decidualized horns); Ang-(1-7) infusion attenuated the increase of PGE2 (12.0 ±
3.2 vs. 5.1 ± 1.3 pmol/mg protein, p < 0.01 control vs. Ang-(1-7) treated decidualized horns). The stable
metabolite of PGI2 (6-keto PGF1α) was increased with decidualization (0.79 ± 0.17 vs. 3.5 ± 0.82 pmol/mg
protein, p < 0.001, non-decidualized vs. decidualized horns). Ang-(1-7) infusion attenuated the increase in 6keto PGF1α in the decidualized horn (3.5 ± 0.82 vs 1.8 ± 0.37 pmol/mg protein, p < 0.05 control vs. Ang-(1-7)
treated decidualized horns). The circulating levels of 6-keto-PGF1a and TXB2 were decreased by Ang-(1-7)
infusion, while no difference was observed in circulating PGE2. Although the global assessment of cleaved
caspase 3 immunostaining, a marker of apoptosis, was unchanged within the Ang-(1-7) decidualized horn,
there were localized decreases in cleaved caspase 3 staining in the luminal region in the decidualized uterus
of Ang-(1-7)-treated rats.
Conclusions: These studies show that increased local uterine Ang-(1-7) alters the uterine prostaglandin
environment, possibly leading to disruptions of early events of decidualization.
Keywords: Prostanoids, Early pregnancy, Angiotensin-(1-7), Decidualization, Apoptosis, Pseudopregnancy
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Background
The outcome of pregnancy depends on the success of
implantation and placentation [1–3]. Cyclooxygenase
(COX)-derived prostanoids (PGE2, PGI2) possess vasoactive, mitogenic and differentiating properties which
regulate numerous maternal-fetal interactions during
normal early pregnancy [2, 4]. Gene targeting experiments have demonstrated that COX2 derived prostanoids are essential for implantation and decidualization
[1, 2, 5]. Prostanoids participate in the regulation of the
angiogenic processes, vascular permeability, apoptosis,
and remodeling of the endometrium during implantation
and decidualization [6–9].
During late pregnancy there is an overexpression of
the local placental renin-angiotensin-system (RAS) [10];
however the physiological role of the stimulated RAS is
unknown in normal pregnancy and in pathophysiological
disorders of pregnancy. Our group provided evidence
that the RAS may play an important role during normal
pregnancy [10, 11], and an adequate balance of the two
main biological active peptides, angiotensin II (Ang II)
and angiotensin-(1-7) (Ang-(1-7)) may be essential for
the maintenance of normal pregnancy. During early
pregnancy Ang-(1-7) staining was found in the implantation site and fetal membranes [11]. Decreased
Ang-(1-7) concentration was found in uterine tissue
from the implantation site as compared to the interimplantation site at day 7 in pregnant rats [11]. Decreased
concentrations of Ang-(1-7) were found in the decidualized uterus compared to the non-decidualized uterus of
pseudopregnant rats [12], suggesting that low levels of
Ang-(1-7) are required for successful decidualization at
early pregnancy. Our overall hypothesis is that Ang-(1-7)
exerts an important regulatory role on prostanoid production in the decidualization process of early gestation.
In order to test this hypothesis, Ang-(1-7) was infused locally into a decidualized uterine horn of a pseudopregnant
rat and its effects on prostanoid concentrations were
evaluated.
Methods
The induction of decidualization and the infusion of
Ang-(1-7) into the uterine horn were described in our
previously published work focused on the analysis of the
effects of Ang-(1-7) treatment on the endocannabinoid
system [13]. During these experiments an additional set
of uterine tissue was frozen at −80 °C for the analysis of
the prostanoids measured in this study. Female Sprague–Dawley rats were obtained from Harlan Laboratories at 10 weeks of age and were ovariectomized under
2 % isofluorane anesthesia. Five days after surgery animals were treated with a hormone regime [17-β estradiol
(0.1, 0.2, or 0.3 μg) and progesterone (1 or 4 mg)]; the
sequence of hormone delivery is as previously published
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[13]. On day 5 of hormone treatment animals were anesthetized with 2 % isofluorane and a left horn was
injected with a bolus of sesame oil (0.1 ml); an osmotic
pump (model 2ML2, pumping rate of 5 μL/h) was implanted subcutaneously on the back and was connected
to the left uterine horn for delivery of 24 μg/kg/h of
Ang-(1-7) or vehicle of sterile sodium phosphate buffer
saline (PBS, pH 7.4) in the two groups of animals. PE60
tubing attached to the minipump was inserted into the
uterus lumen until it reached a plastic cuff placed 1 mm
from the tip of the catheter. Sutures secured the catheter
(before and after the cuff ). The right horn was not
injected or infused and served as a non-decidualized
control in both groups of animals. Five days after surgery
and treatment, animals were sacrificed by decapitation.
This time point was selected based on studies demonstrating peak uterine mass gain in the pseudopregnant
animal [14]. Trunk blood was collected in the presence
of indomethacin (20 μg/mL) in the treated and untreated
animals. The non-infused and infused uterine horns
were removed, weighed, and snap-frozen on dry ice for
tissue prostanoid analysis by ELISA. All procedures were
approved by the Wake Forest School of Medicine Animal Care and Use Committee.
Tissue and plasma prostanoids

Frozen tissues were rapidly weighed and homogenized at
20,000 g in a sodium phosphate buffer saline containing
inhibitors, EDTA and indomethacin. 2 mL (1 mL sample)
and H3-PGE2 was added for recovery. A 50 μL aliquot of
the homogenate was removed for protein determination.
10 mL of acetone was added to 5 ml of homogenate and
vortexed. Samples were then centrifuged at 1500 g for
10 min. Acetone was removed by vacuum centrifugation
and 3 mL of supernatant were transferred into a 12 × 57
borosilicate glass tube, and dried down to 500 μL (Savantno heat). This was repeated until 500 μL of solution was
left. The remaining samples were acidified to pH 4.0 by
adding 50 mM of acetate buffer. The homogenates were
extracted and purified using Sep-Pak columns. Columns
were activated by rinsing with the 5 mL methanol and
5 mL ultrapure H2O. The extracts were assayed using ELISAs for prostaglandin E2, 6 keto PGF1α (the stable metabolite of PGI2), and TxB2 (the stable metabolite of TxA2)
(Assay Designs, Ann Arbor, MI). Tissue sample content
was corrected for recovery and expressed per mg protein.
Plasma was extracted (ethanol and acidified with 1 M
acetate buffer to pH 4.0), purified using Sep-Pak columns,
Sep Pak columns were washed with methanol. After application of the extracted sample to the column, it was
washed with ultra-pure water and hexane; then the sample
was eluted with ethyl acetate and methanol, evaporated,
reconstituted and assayed for PGE2, 6-keto PGF1α and
TxB2 by ELISA (Caymen Chemical, Ann Arbor, MI).
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Immunohistochemistry for Cleaved Caspase-3

The uterus was fixed in 4 % paraformaldehyde, embedded and slides were stained using alkaline phosphatase
detection with an antibody to a marker of apoptosis
cleaved caspase-3 at a 1:50 dilution (Cell Signaling, Denvesa, MA). Six slides from each group were analyzed.
Semi-quantitative analysis was conducted based on grading the intensity of staining from zero (no staining) to
four (high intensity) staining. The scoring was performed
blinded to the treatment. One hundred cells/slide from
four areas (lumen-antimesometrial, lumen-mesometrial,
decidual-mesometrial, decidual-antimesometrial) were
scored using a 1–3 Micro-Imaging Program that connected to a 60× microscope.
Data were analyzed using a two way analysis of variance (2-way ANOVA) followed by Bonferroni’s post hoc
test (GraphPad Software, San Diego, CA) or student t
test. A p value of less than 0.05 was considered statistically different. All data were expressed as mean ± SEM.

Results
In control animals, decidualization was characterized by
a 22.2–fold increase in PGE2 levels, 4.4-fold increase in
6-keto PGF1α, and no significant change in TxB2 levels
(Fig. 1) as compared to the non-decidualized horn. The
predominant prostanoid in the decidualized horn was
PGE2 > 6-keto PGF1α > TxB2, whereas in the nondecidualized uterine horn there was no difference in the
content of the three prostanoids, each approximating
about 1 pmol/mg protein. Ang-(1-7) treatment (Fig. 1a)
into the decidualized horn decreased PGE2 levels as
compared to the control decidualized horn (p < 0.01).
Ang-(1-7) treatment also decreased the levels of 6-keto
PGF1α as compared to the control decidualized horn
(Fig. 1b). There were no significant differences between
the non-decidualized and decidualized horns in TxB2
levels following Ang-(1-7) treatment (Fig. 1c). There
were no differences between the non-decidualized horns
in the control and Ang-(1-7) treated groups.
Our previous study reported no effect of Ang-(1-7)
treatment on gene expression of markers of apoptosis,
including caspase-3 mRNA [13]. In order to evaluate regional distributional changes in caspase-3 associated
with Ang-(1-7) treatment in the uterus, we performed
immunostaining for cleaved caspase-3. Our data show
no signal for cleaved caspase-3 in the non-decidualized
horn. Global assessment of the staining in the four regions of the decidualized horn revealed that Ang-(1-7)
treatment had no effect (Fig. 2 Total). The region with
the greatest staining was in the antimesometrial decidual region (Fig. 2a and c), but semi-quantative assessment of staining was not changed by Ang-(1-7) (55.2 ±
12.6 vs. 70.7 ± 8.4 % apoptoic cell/100 cells, ns) in this
region. However, local assessment of the luminal cells

Fig. 1 Tissue levels of PGE2, (a) 6-keto PGF1α, (b) and TxB2 (c) (pmol/mg
protein) in the non-decidualized and decidualized uterine horns of
control and Ang-(1-7) treated animals. The decidualized horn of
the two groups of animals received locally infused either control
(PBS) or Ang-(1-7) treatment, whereas the non-decidualized horn
of each was untreated. Data are mean ± SEM, n = 9–10, *p < 0.001
(control non-decidualized vs. decidualized horns) #p < 0.05, ##p <
0.01 (control decidualized vs. Ang-(1-7) decidualized horns)

in both the antimesometrial and mesometrial regions
showed a significant reduction in apoptosis measured
by high intensity cleaved caspase-3 immunostaining
with Ang-(1-7) treatment (Fig. 2 Luminal Region and
Fig. 2b and d).
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Fig. 2 Semi-quantitative assessment of staining of cleaved caspase-3, an apoptotic marker, was determined in total and luminal regions of the
control and Ang-(1-7) dedicualized uterus. The % of apoptotic cells when all four regions (luminal and decidual, antimesometrial and mesometrial)
(Total) were combined was not different between control and Ang-(1-7)-treated groups, whereas the % of the stained apoptotic cells in the
mesometrial and antimesometrial luminal regions (Luminal Region) was reduced with Ang-(1-7) treatment. n = 6 animals/group). Representative
immunohistochemical cleaved caspase 3 staining of the control (a and b) and Ang-(1-7) (c and d) decidualized uterus. A = antimesometrial; M =
mesometrial. Scale bar = 200 μm

In order to determine if the local uterine infusion of
Ang-(1-7) as compared to PBS in the decidualized horns
affected circulating levels of prostaglandins, plasma
PGE2, 6-keto PGF1α, and TxB2 were compared in the
two groups of rats (Fig. 3). The group receiving intrauterine Ang-(1-7) into the decidualized horn showed reduced plasma 6-keto PGF1α and TxB2 levels without a
change in PGE2 levels (Fig. 3). As previously published
[13], circulating levels of Ang I (38 ± 4 vs. 35 ± 6 pmol/L,
control vs. Ang-(1-7)) and Ang II (32 ± 3.5 vs. 24 ± 1.5
pmol/L, control vs Ang-(1-7)) were unchanged by the
intra-uterine infusion of Ang-(1-7), but there was an increase in circulating levels of Ang-(1-7) (180 ± 28 vs.
320 ± 55 pmol/L, p < 0.05 control vs. Ang-(1-7) infused).

Fig. 3 Plasma prostanoids (PGE2, 6-keto PGF1α, and TxB2) in animals
that received local intrauterine infused control (PBS) or Ang-(1-7)
treatment. Data are mean ± SEM. n = 7–10, *p < 0.05 vs. Control

Discussion
Prostanoids are important components of decidualization whereby the maternal uterus is remodeled to become receptive to the blastocyst. Prostaglandins have an
obligatory role in the early pregnancy, as evidenced by
indomethacin abolishing or significantly delaying implantation and decidualization. Although decidualization
usually occurs in conjunction with receiving the
implanting blastocyst, mechanical stimulation of the
uterine luminal surface in pseudopregnant rodents can
induce differentiation of uterine stromal cells into
decidual cells in a manner that is similar to blastocyst
implantation. In this study we showed that PGE2 and 6keto PGF1α tissue contents are significantly increased in
the decidualized uterus of the pseudopregnant rat, without a change in TxB2 content. Administration of Ang(1-7) locally into the decidualized uterus results in
significant reduction in the concentration of PGE2 and
6-keto PGF1α suggesting that a local increase in Ang-(17) may interfere with some aspects of prostaglandin
dependent events of decidualization.
In light of our previous work demonstrating that decreased concentrations of Ang II and Ang-(1-7) were
found in the decidualized uterus and in the implantation
versus inter-implantation sites of early pregnancy and
pseudopregnancy [11, 12], our current study shows that
exposure to higher levels of local uterine Ang-(1-7)
changes the prostanoid profile of the uterus and suggests
that an activated RAS alters the normal profile of prostanoids in early pregnancy. The mechanism for this effect
may be an action of Ang-(1-7) on the regulation of the
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synthetic enzymes of the prostanoids, including COX2,
PGE synthase and/or PGI synthase at the level of the
gene or protein. Future studies are required to determine the site of regulation.
As we previously published [13], there was a 9.6 fold
increase in weight in the control decidualized horn as
compared to the non-decidualized horn (1722 ± 103 vs
179.7 ± 7.1 mg, p < 0.001); the weight of the decidualized
horn was not altered by Ang-(1-7) infusion (1674 ±
55.9 mg). Permeability measured as the cpm of radiolabeled I125 albumin in the uterus relative to the specific
activity of skeletal muscle albumin increased with decidualization (7.1 ± 0.5 vs 3.1 ± 0.2 cpm uterus/cpm skeletal
muscle, p < 0.01), but was unchanged in the decidualized
horn with Ang-(1-7) treatment (7.5 ± 0.9 cpm uterus/
cpm skeletal muscle) [13]. As previously published, immunostaining of vimentin, a cellular marker of decidualized cells, clearly revealed distinct patterns in the
intensity of staining in the decidualized uterus with the
mesometrial pole showing more intense staining than
the antimesometrial pole; however, there was no effect
of Ang-(1-7) on the intensity of staining of vimentin in
the decidualized horn [13]. In association with the increase in permeability of the decidualized horn, VEGF
mRNA was increased: however, in contrast to the other
indices of decidualization, Ang-(1-7) treatment resulted
in a further increase in VEGF mRNA in association with
the decrease in PGE2 and PGF1α. The increase in VEGF
mRNA is consistent with both its angiogenic and permeability increasing properties [15]. The increase in uterine
weight and permeability were accompanied with increases in PGE1 and 6-keto PGF1α consistent with previous reports for their involvement in the events of
decidualization [9]. The earliest events of pregnancy
such as permeability and increase in the uterine mass
can be induced by local uterine PGE2 infusion [9]. The
fact that Ang-(1-7) reduced PGE2 and 6-keto PGF1α
without a change in weight and permeability was unexpected in light of previous reports by Hamilton et al. [9]
who demonstrated that blockade of PGE1 and PGF1α
using indomethacin reduced decidualized uterine weight
and permeability. One explanation for the difference in
our and their findings is that Ang-(1-7) only partially reduced PGE2 and 6-keo PGF1α and these levels of reduction may not be sufficient to affect an overall change in
uterine weight and permeability. Our study does not
eliminate the possibility that Ang-(1-7) could be causing
other local changes in association with decidualization.
For example, measurement of regional changes in a
marker of apoptosis revealed localized changes in the
decidualized uterus in the luminal region. Ang-(1-7) treatment affects local apoptosis without causing a change in
the total uterine weight, permeability, or the total tissue
content of mRNA caspase-3. That an increased Ang-(1-7)
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may be detrimental in early pregnancy is consistent
with our observation of its increase in human placenta at the 1st trimester of aborted pregnancy [16].
Further studies are required to assess how the production of prostaglandins was attenuated by increased levels of Ang-(1-7) and whether local
changes of Ang-(1-7) and prostanoids in the implantation site are important in influencing the success of implantation. Recent work in rodent models
has described a prominent role of prostanoid levels
in decidua during the pathogenesis of preeclampsia
[17]. In their model of preeclampsia the BPH/5 mice,
a single administration of Cox2 inhibitor during
early (E6.5 days) decidualization improved fetal
growth and attenuated late gestational hypertension.
Future studies will be important in determining the
balance of RAS and prostanoid levels in adverse
pregnancy outcomes, such as preeclampsia.
Circulating levels of PGF1α and TxB2 were decreased with Ang-(1-7) local uterine infusion, whereas
plasma PGE2 did not change. In our previous publication we demonstrated that local uterine infusion of
Ang-(1-7) is associated with increased circulating
levels of Ang-(1-7) [13]. The reduction in circulating
levels of PGF1α is consistent with the reduction in its
uterine content with Ang-(1-7) local infusion and
could be explained by the reduced release into the
circulation rather than a direct effect of the increased
circulating Ang-(1-7) with the infusion. Comparison
of the biochemical changes in non-decidualized horns
in animals with and without Ang-(1-7) treatment in
this and our previous study [13] showed that there
were comparable levels of PGE2, 6-keto- PGF1α, and
TxB2, demonstrating that this spill over into the circulation from the infused horn had no effect on the
non-decidualized horns. Because TxB2 tissue content
was not significantly affected by Ang-(1-7), its reduction in the circulation may be due to systemic effects
of Ang-(1-7) on TxB2. Our data demonstrate that the
reduction in uterine PGE2 with Ang-(1-7) is not
reflected in plasma PGE2 levels.

Conclusions
In summary, these studies demonstrate that elevated
Ang-(1-7) in the uterine decidualized horn alters the
profile of uterine prostanoids, PGE2 and 6-keto PGF1α.
Local apoptosis in the luminal region was reduced with
Ang-(1-7). The direct connection of these events to
prostaglandins is yet to be determined. Because of the
critical role of prostanoids in the early events of pregnancy, the down-regulation of prostanoids by elevated
Ang-(1-7) may lead to complications in the early events
of pregnancy.
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